Geographical diffusion of prazosin across Veterans Health Administration: Examination of regional variation in daily dosing and quality indicators among veterans with posttraumatic stress disorder
Thad E. Abrams, MD, MS, et al.
Posttraumatic stress disorder (PTSD) is a common
and disabling illness for many of our returning
Veterans. Prazosin is an innovative and effective
therapy that is not considered a conventional psychiatric
treatment; thus, examining prazosin diffusion
can potentially serve as an indicator for diffusion of
innovation and as an indicator of PTSD treatment
more broadly. This article demonstrates the current
regional pattern of diffusion and examines prazosin
distribution compared with quality indicators in order
to examine whether there are regional disparities
in PTSD pharmacotherapy. Prazosin utilization and
dosing remain disparate across the geographic bands
outside of Puget Sound, Washington, yet do not appear
to reflect a quality prescribing gap more broadly.
http://dx.doi.org/10.1682/JRRD.2014.08.0200
Volume 52 Number 5, 2015
Pages 619 — 628
View HTML ¦ View PDF ¦ Contents Vol. 52, No.5
This article and any supplementary material should be cited as follows:
Abrams TE, Lund BC, Alexander B, Bernardy NC, Friedman MJ. Geographical diffusion of prazosin across Veterans Health Administration: Examination of regional variation in daily dosing and quality indicators among veterans with posttraumatic stress disorder. J Rehabil Res Dev. 2015;52(5):619–28.
http://dx.doi.org/10.1682/JRRD.2014.08.0200
Abrams TE, Lund BC, Alexander B, Bernardy NC, Friedman MJ. Geographical diffusion of prazosin across Veterans Health Administration: Examination of regional variation in daily dosing and quality indicators among veterans with posttraumatic stress disorder. J Rehabil Res Dev. 2015;52(5):619–28.
http://dx.doi.org/10.1682/JRRD.2014.08.0200
Go to TOP
Last Reviewed or Updated Wednesday, September 23, 2015 9:47 AM
